D. Western Therapeutics Institute, Inc. provided earnings guidance for the full year ending December 31, 2020. For the year, the company expects to report net sales of JPY 310 million, operating loss of JPY 390 million and net loss attributable to owners of the parent was JPY 340 million or JPY 12.94 per share.